Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 398

1.

Cancer stem cell metabolism.

Peiris-Pagès M, Martinez-Outschoorn UE, Pestell RG, Sotgia F, Lisanti MP.

Breast Cancer Res. 2016 May 24;18(1):55. doi: 10.1186/s13058-016-0712-6. Review.

2.

The retinal determination gene network: from developmental regulator to cancer therapeutic target.

Kong D, Liu Y, Liu Q, Han N, Zhang C, Pestell RG, Wu K, Wu G.

Oncotarget. 2016 May 17. doi: 10.18632/oncotarget.9394. [Epub ahead of print] Review.

3.

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy.

Di Sante G, Casimiro MC, Pestell TG, Pestell RG.

J Vis Exp. 2016 May 4;(111). doi: 10.3791/53657.

PMID:
27168174
4.

Cancer metabolism: a therapeutic perspective.

Martinez-Outschoorn UE, Peiris-Pagés M, Pestell RG, Sotgia F, Lisanti MP.

Nat Rev Clin Oncol. 2016 May 4. doi: 10.1038/nrclinonc.2016.60. [Epub ahead of print] Review.

PMID:
27141887
5.

A direct quantification method for measuring plasma MicroRNAs identified potential biomarkers for detecting metastatic breast cancer.

Zhao Q, Deng S, Wang G, Liu C, Meng L, Qiao S, Shen L, Zhang Y, Lü J, Li W, Zhang Y, Wang M, Pestell RG, Liang C, Yu Z.

Oncotarget. 2016 Mar 8. doi: 10.18632/oncotarget.7990. [Epub ahead of print]

6.

Breast Cancer Stem Cell Isolation.

Jiao X, Rizvanov AA, Cristofanilli M, Miftakhova RR, Pestell RG.

Methods Mol Biol. 2016;1406:121-35. doi: 10.1007/978-1-4939-3444-7_10.

PMID:
26820950
7.

The role of CD44 in epithelial-mesenchymal transition and cancer development.

Xu H, Tian Y, Yuan X, Wu H, Liu Q, Pestell RG, Wu K.

Onco Targets Ther. 2015 Dec 16;8:3783-92. doi: 10.2147/OTT.S95470. eCollection 2015. Review.

8.

Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.

Marampon F, Gravina GL, Ju X, Vetuschi A, Sferra R, Casimiro MC, Pompili S, Festuccia C, Colapietro A, Gaudio E, Di Cesare E, Tombolini V, Pestell RG.

Oncotarget. 2016 Feb 2;7(5):5383-400. doi: 10.18632/oncotarget.6579.

9.

Cyclin D1 Promotes Androgen-Dependent DNA Damage Repair in Prostate Cancer Cells.

Casimiro MC, Di Sante G, Ju X, Li Z, Chen K, Crosariol M, Yaman I, Gormley M, Meng H, Lisanti MP, Pestell RG.

Cancer Res. 2016 Jan 15;76(2):329-38. doi: 10.1158/0008-5472.CAN-15-0999. Epub 2015 Nov 18.

PMID:
26582866
10.

Mitochondrial mass and DNA repair in breast cancer stem cells.

Pestell RG, Fatatis A, Jiao X.

Oncotarget. 2015 Nov 17;6(36):38442-3. doi: 10.18632/oncotarget.6305. No abstract available.

11.

Erratum: Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts.

Trerotola M, Ganguly KK, Fazli L, Fedele C, Lu H, Dutta A, Liu Q, De Angelis T, Riddell LW, Riobo NA, Gleave ME, Zoubeidi A, Pestell RG, Altieri DC, Languino LR.

Oncotarget. 2015 Oct 20;6(32):34038. doi: 10.18632/oncotarget.6187. No abstract available.

12.

EglN2 associates with the NRF1-PGC1α complex and controls mitochondrial function in breast cancer.

Zhang J, Wang C, Chen X, Takada M, Fan C, Zheng X, Wen H, Liu Y, Wang C, Pestell RG, Aird KM, Kaelin WG Jr, Liu XS, Zhang Q.

EMBO J. 2015 Dec 2;34(23):2953-70. doi: 10.15252/embj.201591437. Epub 2015 Oct 22.

PMID:
26492917
13.

Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells.

Lamb R, Ozsvari B, Bonuccelli G, Smith DL, Pestell RG, Martinez-Outschoorn UE, Clarke RB, Sotgia F, Lisanti MP.

Oncotarget. 2015 Sep 8;6(26):21892-905.

14.

Kinase independent oncogenic cyclin D1.

Casimiro MC, Arnold A, Pestell RG.

Aging (Albany NY). 2015 Jul;7(7):455-6. No abstract available.

15.

Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts.

Trerotola M, Ganguly KK, Fazli L, Fedele C, Lu H, Dutta A, Liu Q, De Angelis T, Riddell LW, Riobo NA, Gleave ME, Zoubeidi A, Pestell RG, Altieri DC, Languino LR.

Oncotarget. 2015 Jun 10;6(16):14318-28. Erratum in: Oncotarget. 2015 Oct 20;6(32):34038.

16.

Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis.

Casimiro MC, Di Sante G, Crosariol M, Loro E, Dampier W, Ertel A, Yu Z, Saria EA, Papanikolaou A, Li Z, Wang C, Addya S, Lisanti MP, Fortina P, Cardiff RD, Tozeren A, Knudsen ES, Arnold A, Pestell RG.

Oncotarget. 2015 Apr 20;6(11):8525-38.

17.

The endogenous cell-fate factor dachshund restrains prostate epithelial cell migration via repression of cytokine secretion via a cxcl signaling module.

Chen K, Wu K, Jiao X, Wang L, Ju X, Wang M, Di Sante G, Xu S, Wang Q, Li K, Sun X, Xu C, Li Z, Casimiro MC, Ertel A, Addya S, McCue PA, Lisanti MP, Wang C, Davis RJ, Mardon G, Pestell RG.

Cancer Res. 2015 May 15;75(10):1992-2004. doi: 10.1158/0008-5472.CAN-14-0611. Epub 2015 Mar 13.

18.

Antibiotics for cancer therapy.

Pestell RG, Rizvanov AA.

Oncotarget. 2015 Feb 20;6(5):2587-8. No abstract available.

19.

Targeting tumor-initiating cells: eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction.

Lamb R, Harrison H, Smith DL, Townsend PA, Jackson T, Ozsvari B, Martinez-Outschoorn UE, Pestell RG, Howell A, Lisanti MP, Sotgia F.

Oncotarget. 2015 Mar 10;6(7):4585-601.

20.

Sirt1-deficient mice have hypogonadotropic hypogonadism due to defective GnRH neuronal migration.

Di Sante G, Wang L, Wang C, Jiao X, Casimiro MC, Chen K, Pestell TG, Yaman I, Di Rocco A, Sun X, Horio Y, Powell MJ, He X, McBurney MW, Pestell RG.

Mol Endocrinol. 2015 Feb;29(2):200-12. doi: 10.1210/me.2014-1228. Epub 2014 Dec 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk